Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States

Julia L Marcus; Jonathan M Snowden; Mara E Murray Horwitz; Sengwee Toh; Casie Horgan; Rong Chen Tilney; Rajani Rajbhandari; Soowoo Back; Daniel J Westreich

doi:10.1093/cid/ciz791

Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States

Clin Infect Dis. 2020 May 6;70(10):2221-2223. doi: 10.1093/cid/ciz791.

Authors

Julia L Marcus¹, Jonathan M Snowden², Mara E Murray Horwitz¹, Sengwee Toh¹, Casie Horgan¹, Rong Chen Tilney¹, Rajani Rajbhandari¹, Soowoo Back¹, Daniel J Westreich³

Affiliations

¹ Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.
² School of Public Health, Oregon Health & Science University─Portland State University.
³ Department of Epidemiology, University of North Carolina at Chapel Hill.

Abstract

Concerns have been raised about progestin-containing contraceptives and the risk of human immunodeficiency virus (HIV) acquisition. Based on health insurance data from women in the United States with intrauterine device (IUD) insertions during 2011-2018, there was no increased risk of incident HIV diagnosis for levonorgestrel-releasing IUDs versus copper IUDs.

Keywords: copper intrauterine devices; hormone releasing intrauterine devices; human immunodeficiency virus; intrauterine devices; long-acting reversible contraception.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Female
HIV
HIV Infections* / epidemiology
Humans
Intrauterine Devices, Copper*
Intrauterine Devices, Medicated* / adverse effects
Levonorgestrel / adverse effects
United States / epidemiology

Substances

Levonorgestrel

Abstract

Publication types

MeSH terms

Substances

Grants and funding